Citations 1
Trial in Progress: A Phase 1b/2 Study of GB5121, a Brain-Penetrant, Potent, Highly Selective, and Irreversible BTK Inhibitor for Relapsed/Refractory Primary/Secondary CNS Lymphoma and Primary Vitreoretinal Lymphoma
Soussain, Carole , Lewis, Katharine L. , Fox, Judith, Ward, Renee, Peterson, Caryn, Cravets, Matt , Mathias, Anita, Sosa, Judith, Ding, Zhaoqing, Yusuf, Isharat, Rose, Mark J., Steinberg, Marcos W, Lewis, Katharine L , Issa, Samar , Grommes, Christian , Kirby, Brian J, Tun, Han W.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12068-12069
